Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Hyperoxemia Treatment Market: By Indication: Vertigo, Seizures, Pneumonia, Cataract, Vasodilation, Tissue Necrosis, Metabolic Acidosis; By End Use: Hospitals, Ambulatory Surgical Centres, Specialty Clinics; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments
Global Hyperoxemia Treatment Market Outlook
The global hyperoxemia treatment market witnessed a healthy growth in the historical period of 2016-2020, aided by the advancement in research and development. The market is being aided by the growth of the oxygen therapy market, which is expected to grow at a CAGR of 8% during the forecast period of 2021-2026 to reach a value of USD 17 billion by 2026
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America Expected to be a Key Contributor to the Global Market for Hyperoxemia Treatment
North America is expected to have a major share in terms of revenue in the hyperoxemia treatment industry owing to improved medications, a rise in R&D, and increased usage of modern instruments in laboratories and hospitals. The rising prevalence of hyperoxemia in Europe is expected to contribute to the growth of hyperoxemia treatment industry in the region. The rising awareness among people about diseases like hyperoxemia is driving them to opt for treatments. Moreover, the increasing demand for new treatment options is also expected to spur the hyperoxemia treatment industry growth, particularly in the Asia Pacific region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Hyperoxemia Treatment: Industry Definition and Segmentation
Hyperoxemia is a condition when there is an increase in the level of arterial oxygen partial pressure (PaO2) to a greater extent, up to 120 mHg. Hyperoxemia generally occurs when the tissues, cells, and organs are exposed to excess oxygen supply or higher than normal oxygen partial pressure.
Based on indication, the market can be divided into:
- Vertigo
- Seizures
- Pneumonia
- Cataract
- Vasodilation
- Tissue Necrosis
- Metabolic Acidosis
Based on end use, the market can be divided into:
- Hospitals
- Ambulatory Surgical Centres
- Specialty Clinics
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Advancements in Research and Development is Driving the Market Growth
The advancements in research and development activities, increased usage of modern equipment in hospitals and clinics, and improved medications are driving the global hyperoxemia treatment industry growth. The market is expected to register significant growth since there is only one therapy given to the patients. Moreover, the increasing awareness in people regarding medications and the rising demand for new treatments is driving the hyperoxemia market forward. In addition to this, hyperoxemia treatment also helps in detecting cardiac arrest, thus, as a result, furthering the growth of the hyperoxemia treatment industry.
Key Industry Players in the Global Hyperoxemia Treatment Market
The report gives a detailed analysis of the following key players in the global hyperoxemia treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Hamilton Medical AG
- GaleMed Corporation
- Vapotherm, Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on Porter's five forces model, along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Indication, End Use, Region |
| Breakup by Indication | Vertigo, Seizures, Pneumonia, Cataract, Vasodilation, Tissue Necrosis, Metabolic Acidosis |
| Breakup by End Use | Hospitals, Ambulatory Surgical Centres, Specialty Clinics |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Hamilton Medical AG, GaleMed Corporation, Vapotherm, Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Hyperoxemia Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Hyperoxemia Treatment Historical Market (2016-2020)
8.3 Global Hyperoxemia Treatment Market Forecast (2021-2026)
8.4 Global Hyperoxemia Treatment Market by Indication
8.4.1 Vertigo
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Seizures
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Pneumonia
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Cataract
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2016-2020)
8.4.4.3 Forecast Trend (2021-2026)
8.4.5 Vasodilation
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2016-2020)
8.4.5.3 Forecast Trend (2021-2026)
8.4.6 Tissue Necrosis
8.4.6.1 Market Share
8.4.6.2 Historical Trend (2016-2020)
8.4.6.3 Forecast Trend (2021-2026)
8.4.7 Metabolic Acidosis
8.4.7.1 Market Share
8.4.7.2 Historical Trend (2016-2020)
8.4.7.3 Forecast Trend (2021-2026)
8.5 Global Hyperoxemia Treatment Market by End Use
8.5.1 Hospitals
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Ambulatory Surgical Centres
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Specialty Clinics
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2016-2020)
8.5.3.3 Forecast Trend (2021-2026)
8.6 Global Hyperoxemia Treatment Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Hamilton Medical AG
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 GaleMed Corporation
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Vapotherm, Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Hyperoxemia Treatment Market: Key Industry Highlights, 2016 and 2026
2. Global Hyperoxemia Treatment Historical Market: Breakup by Indication (USD Billion), 2016-2020
3. Global Hyperoxemia Treatment Market Forecast: Breakup by Indication (USD Billion), 2021-2026
4. Global Hyperoxemia Treatment Historical Market: Breakup by End Use (USD Billion), 2016-2020
5. Global Hyperoxemia Treatment Market Forecast: Breakup by End Use (USD Billion), 2021-2026
6. Global Hyperoxemia Treatment Historical Market: Breakup by Region (USD Billion), 2016-2020
7. Global Hyperoxemia Treatment Market Forecast: Breakup by Region (USD Billion), 2021-2026
8. North America Hyperoxemia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
9. North America Hyperoxemia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
10. Europe Hyperoxemia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
11. Europe Hyperoxemia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
12. Asia Pacific Hyperoxemia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
13. Asia Pacific Hyperoxemia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Latin America Hyperoxemia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Latin America Hyperoxemia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Middle East and Africa Hyperoxemia Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Middle East and Africa Hyperoxemia Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Global Hyperoxemia Treatment Market Structure
Key Questions Answered in the Report
The global hyperoxemia treatment market is being driven by the growth of the oxygen therapy industry, which is projected to grow at a CAGR of 8% between 2021 and 2026.
The oxygen therapy market is estimated to reach about USD 17 billion by 2026, further supporting the growth of the hyperoxemia treatment industry.
The major drivers of the industry, such as the increasing prevalence of hyperoxemia and the rapid advancements in R&D, are aiding the growth of the market.
The key trend guiding the growth of the market is the rising demand for new treatments for hyperoxemia.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The indications of hyperoxemia include vertigo, seizures, pneumonia, cataract, vasodilation, tissue necrosis and metabolic acidosis.
The major end-uses in the industry are hospitals, ambulatory surgical centres, and specialty clinics.
The major players in the industry are Hamilton Medical AG, GaleMed Corporation, and Vapotherm, Inc., among others.
Analyst Review
The global hyperoxemia treatment market is being driven by the increasing research and development activities. The market is expected to be aided by the oxygen therapy market, which is projected to witness a CAGR of 8% between 2021 and 2026 to reach USD 17 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By the types of indications, the industry can be divided into vertigo, seizures, pneumonia, cataract, vasodilation, tissue necrosis, and metabolic acidosis. Based on end uses, the industry is majorly divided into hospitals, ambulatory surgical centres, and specialty clinics. The major regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Hamilton Medical AG, GaleMed Corporation, and Vapotherm, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global cancer immunotherapy market stood at a value of around USD 86,607 million in 2020. The market is further expected to grow at a CAGR of 9.7% in the forecast period of 2021-2026 to attain a v...
The global sickle cell disease treatment market stood at a value of around USD 3.4 billion in 2020. The market is further expected to grow at a CAGR of 16.9% in the forecast period of 2021-2026 to att...
The global dry eye disease treatment market attained a value of nearly USD 5 billion in 2020, driven by the rising prevalence of eye complications among the growing geriatric population. Aided by the ...
The global polymyalgia rheumatica treatment market attained a value of nearly USD 177 million in 2020, driven by the introduction of various clinical programs. Aided by the growing demand for physical...
The global haematologic malignancies treatment market attained a value of USD 52.1 billion in 2020, driven by the rising prevalence of hematologic malignancies. Aided by the increasing R&D investment,...
NEWSLETTER